MeiraGTx Holdings plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MGTX | IRD | DSGN | OCGN | RGNX | STOK | |
|---|---|---|---|---|---|---|
| Market cap | 904.72M | 355.25M | 665.24M | 296.55M | 508.96M | 1.78B |
| P/E (TTM) | 10.8 | — | — | — | — | — |
| Forward P/E | -6.2 | -6.0 | -6.6 | -3.5 | -2.6 | -7.3 |
| Price/book | 4.1 | -27.2 | 3.0 | -16.8 | 5.8 | 5.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +12.01% | +110.34% | +54.73% | −36.59% | −30.98% | +22.16% |
| Today | −1.05% | +8.65% | +2.80% | +17.35% | +1.05% | +1.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MGTX news ›MeiraGTx Holdings PLC (MGTX) – What Are Brokerages Thinking About This Stock?
Posted by Tristan Rich on Nov 1st, 2026 Get Our Latest Analysis on MeiraGTx MeiraGTx Holdings plc is a clinical-stage biotechnology company focused on developing gene therapies for serious diseases with limited treatment options. The…
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
LONDON and NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage genetic me... MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of…
MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting
The posters will be available on the Posters and Publications page of the Company’s website after their respective conference presentation times. The details of the poster presentations are as follows: Together, this work establishes a…
Bank of America Securities Remains a Buy on Meiragtx Holdings (MGTX)
In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on Meiragtx Holdings, with a price target of $19.00. Stranahan covers the Healthcare sector, focusing on stocks such as Moderna, Agios…
MeiraGTx CFO Richard Giroux sells 56,000 shares
MeiraGTx Holdings plc (Nasdaq: MGTX) is a clinical-stage genetic medicines company with late-stage programs in eye disease, Parkinson’s and xerostomia. - [Form 4] MeiraGTx Holdings plc Insider Trading Activity MeiraGTx CFO Richard Giroux…
MeiraGTx officer proposes sale of 56,000 shares
GameSquare Announces The "Grand Theft Auto" Effect Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update Cipher Digital Announces Date of Third Quarter 2026 Business Update Conference Call The securities…
MeiraGTx CFO Richard Giroux Executes Sale of 56,000 Shares Under Rule 10b5-1 Plan
On October 20, 2026, Richard Giroux, CFO and COO of MeiraGTx Holdings plc, disclosed via a Form 4 filing the sale of 56,000 ordinary shares conducted that day under a pre-established Rule 10b5-1 trading plan. Per the SEC Form 4 filing,…
MeiraGTx: The Data Held Up, The Valuation Didn't (Rating Downgrade)
MeiraGTx remains focused on AAV2-hAQP1 for radiation-induced xerostomia, with the pivotal AQUAx2 trial underway. Read more on MGTX stock here. - MeiraGTx remains focused on AAV2-hAQP1 for radiation-induced xerostomia, with the pivotal…
MeiraGTx (NASDAQ:MGTX) Insider Stuart Naylor Sells 27,659 Shares of Stock
MeiraGTx Holdings PLC (NASDAQ:MGTX – Get Free Report) insider Stuart Naylor sold 27,659 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $10.64, for a total transaction of…
More from 1 other outlet
Piper Sandler Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)
In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Meiragtx Holdings, with a price target of $30.00. Bratzel covers the Healthcare sector, focusing on stocks such as Abivax SA Sponsored ADR, BioMarin…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- markets.businessinsider.com7
- stocktitan.net3
- defenseworld.net1
- gurufocus.com1
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.